Susquehanna International Group
CLRBW

Susquehanna International Group’s Cellectar Biosciences, Inc. CLRBW Stock Holding History

Susquehanna International Group’s Portfolio CLRBW Stock Details CLRBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-40,476
Closed -$2K – 11244
2019
Q2 		$2K Sell
40,476
-400
-1% -$30 ﹤0.01% 10126
2019
Q1 		$4K Buy
40,876
+8,810
+27% +$774 ﹤0.01% 8683
2018
Q4 		$1K Buy
32,066
+5
+0% – ﹤0.01% 8816
2018
Q3 		$3K Sell
32,061
-180
-0.6% -$28 ﹤0.01% 9071
2018
Q2 		$3K Buy
+32,241
New +$7.98K ﹤0.01% 9489

Susquehanna International Group's CLRBW Position: Q3 2019 in Review

Susquehanna International Group sold out of Cellectar Biosciences, Inc. (CLRBW) in Q3 2019, closing a stake of 40,476 shares — an estimated $2K sold.

Susquehanna International Group first reported a position in CLRBW in Q2 2018 and held it in 5 quarters. The position peaked at $4K in Q1 2019. 0 funds tracked by Wall St. Rank hold CLRBW as of Q3 2019.

  • Susquehanna International Group reported no remaining Cellectar Biosciences, Inc. position as of Q3 2019 after selling out during the quarter.
  • Susquehanna International Group sold 40,476 Cellectar Biosciences, Inc. shares in Q3 2019, an estimated $2K.
  • Susquehanna International Group first reported a position in Cellectar Biosciences, Inc. in Q2 2018 and held it in 5 quarters.
  • Susquehanna International Group's Cellectar Biosciences, Inc. position peaked at $4K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Cellectar Biosciences, Inc. as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.